危重症患者对比剂相关急性肾损伤:系统评价与贝叶斯Meta分析
该系统评价与贝叶斯Meta分析评估危重症患者碘对比剂暴露后急性肾损伤的发生率。共纳入10项研究,仅4项考虑了基线急性肾损伤风险,其中3项通过患者匹配(560例)进行客观Meta分析。结果显示碘对比剂未显著增加急性肾损伤发生率(OR 0.95,95%最高后验密度区间0.45-1.62)。贝叶斯分析表明,要得出对比剂显著增加急性肾损伤的结论,需赋予既往无对照报告3-12倍于匹配研究的证据权重。
要点
- 匹配队列研究Meta分析(3项,560例)未发现危重症患者碘对比剂暴露显著增加急性肾损伤(OR 0.95,95%HPDI 0.45-1.62)。
- 10项研究中仅4项考虑基线急性肾损伤风险,其中3项通过患者匹配纳入Meta分析。
- 贝叶斯分析显示,要得出对比剂显著致急性肾损伤的结论,需赋予既往无对照报告3-12倍于匹配研究的证据权重。
- 该系统评价提示危重症患者对比剂相关急性肾损伤的归因风险可能被高估。
适用人群与场景
- 危重症患者(ICU人群),比较碘对比剂暴露与匹配未暴露患者。
研究设计与关键结果
- 系统评价共纳入10项研究,仅4项考虑基线急性肾损伤风险,其中3项通过患者匹配(560例)纳入Meta分析。
- 3项匹配队列研究的Meta分析未发现碘对比剂增加急性肾损伤发生率(OR 0.95,95%最高后验密度区间0.45-1.62)。
- 贝叶斯分析表明,要得出对比剂显著增加急性肾损伤的结论,需赋予既往无对照报告3-12倍于匹配研究的证据权重。
证据类型、等级与局限
- 证据类型:系统评价与贝叶斯Meta分析(纳入匹配队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该系统评价结果提示,危重症患者中碘对比剂暴露与急性肾损伤的归因关联可能被既往无对照研究高估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Critically ill patients, among whom acute kidney injury is common, are often considered particularly vulnerable to iodinated contrast medium nephrotoxicity. However, the attributable incidence remains uncertain given the paucity of observational studies including a control group. This study assessed acute kidney injury incidence attributable to iodinated contrast media in critically ill patients based on new data accounting for sample and effect size and including a control group.
METHODS: Systematic review of studies measuring incidence of acute kidney injury in critically ill patients following contrast medium exposure compared to matched unexposed patients. Patient-level meta-analysis implementing a Bayesian nested mixed effects multiple logistic regression model.
RESULTS: Ten studies were identified; only four took into account the baseline acute kidney injury risk, three by patient matching (560 patients). Objective meta-analysis of these three studies (vague and impartial a priori hypothesis concerning attributable acute kidney injury risk) did not find that iodinated contrast media increased the incidence of acute kidney injury (odds ratio 0.95, 95% highest posterior density interval 0.45-1.62). Bayesian analysis demonstrated that, to conclude in favor of a statistically significant incidence of acute kidney injury attributable to contrast media despite this observed lack of association, one's a priori belief would have to be very strongly biased, assigning to previous uncontrolled reports 3-12 times the weight of evidence strength provided by the matched studies including a control group.
CONCLUSIONS: Meta-analysis of matched cohort studies of iodinated contrast medium exposure does not support a significant incidence of acute kidney injury attributable to iodinated contrast media in critically ill patients.
参考来源
- Ehrmann S, Quartin A, Hobbs BP, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017. PMID: 28197679. doi:10.1007/s00134-017-4700-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。